Home Halogens (2E)-1-(4-bromophenyl)-3-phenylprop-2-en-1-one

(2E)-1-(4-bromophenyl)-3-phenylprop-2-en-1-one

CAS No.:
2403-27-2
Catalog Number:
AG00BD81
Molecular Formula:
C15H11BrO
Molecular Weight:
287.1512
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
Product Description
Catalog Number:
AG00BD81
Chemical Name:
(2E)-1-(4-bromophenyl)-3-phenylprop-2-en-1-one
CAS Number:
2403-27-2
Molecular Formula:
C15H11BrO
Molecular Weight:
287.1512
MDL Number:
MFCD00017841
IUPAC Name:
(E)-1-(4-bromophenyl)-3-phenylprop-2-en-1-one
InChI:
InChI=1S/C15H11BrO/c16-14-9-7-13(8-10-14)15(17)11-6-12-4-2-1-3-5-12/h1-11H/b11-6+
InChI Key:
QMHDTKUBDZUMNH-IZZDOVSWSA-N
SMILES:
Brc1ccc(cc1)C(=O)C=Cc1ccccc1
NSC Number:
28483
Properties
Complexity:
271  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
1  
Exact Mass:
285.999g/mol
Formal Charge:
0
Heavy Atom Count:
17  
Hydrogen Bond Acceptor Count:
1  
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
287.156g/mol
Monoisotopic Mass:
285.999g/mol
Rotatable Bond Count:
3  
Topological Polar Surface Area:
17.1A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
3.8  
Literature
Title Journal
Synthesis and anti Methicillin resistant Staphylococcus aureus activity of substituted chalcones alone and in combination with non-beta-lactam antibiotics. Bioorganic & medicinal chemistry letters 20120715
Synthesis of chalcone derivatives as potential anti-diabetic agents. Bioorganic & medicinal chemistry letters 20120615
Syntheses and evaluation of 3-(3-bromo phenyl)-5-phenyl-1-(thiazolo [4,5-b] quinoxaline-2-yl)-2-pyrazoline derivatives. European journal of medicinal chemistry 20080801
Properties